Deep Track Capital, LP - 30 Jun 2025 SCHEDULE 13G/A Report for MBX Biosciences, Inc. Common Stock, $0.0001 par value per share (MBX)

Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Capital, LP
Security
MBX Biosciences, Inc. Common Stock, $0.0001 par value per share
Symbol
MBX
Shares outstanding
33,413,618 shares
Disclosed Ownership
2,188,592 shares
Ownership
6.6%
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 08:48:45 UTC
Date of event
30 Jun 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Deep Track Capital, LP disclosed 6.6% ownership in MBX Biosciences, Inc. Common Stock, $0.0001 par value per share (MBX) on 30 Jun 2025."

Quick Takeaways

  • Deep Track Capital, LP filed SCHEDULE 13G/A for MBX Biosciences, Inc. Common Stock, $0.0001 par value per share (MBX).
  • Disclosed ownership: 6.6%.
  • Date of event: 30 Jun 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Aug 2025, 08:48.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Capital, LP 6.6% 2,188,592 0 2,188,592 /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser
Deep Track Biotechnology Master Fund, Ltd. 6.6% 2,188,592 0 2,188,592 /s/ David Kroin David Kroin, Director
David Kroin 6.6% 2,188,592 0 2,188,592 /s/ David Kroin David Kroin

Sponsored